EIDETICA Trademark

Trademark Overview

On Wednesday, December 17, 2008, a trademark application was filed for EIDETICA with the United States Patent and Trademark Office. The USPTO has given the EIDETICA trademark a serial number of 77634726. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2012. This trademark is owned by Eidetica Biopharma GmbH. The EIDETICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for metabolic disorders, diabetes, infectious diseases, blood disorders, coagulation disorders, and hormonal and enzyme-replacement therapies
eidetica

General Information

Serial Number77634726
Word MarkEIDETICA
Filing DateWednesday, December 17, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for metabolic disorders, diabetes, infectious diseases, blood disorders, coagulation disorders, and hormonal and enzyme-replacement therapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 22, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEidetica Biopharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressZug 6300
CH
Party NameEidetica Biopharma GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Monday, February 6, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 6, 2012ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 6, 2011EXTENSION 4 GRANTED
Friday, July 1, 2011EXTENSION 4 FILED
Friday, July 1, 2011TEAS EXTENSION RECEIVED
Thursday, January 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 19, 2011EXTENSION 3 GRANTED
Thursday, December 30, 2010EXTENSION 3 FILED
Thursday, December 30, 2010TEAS EXTENSION RECEIVED
Friday, July 9, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 8, 2010EXTENSION 2 GRANTED
Thursday, July 1, 2010EXTENSION 2 FILED
Thursday, July 1, 2010TEAS EXTENSION RECEIVED
Wednesday, January 27, 2010EXTENSION 1 GRANTED
Thursday, December 10, 2009EXTENSION 1 FILED
Monday, January 25, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 10, 2009TEAS EXTENSION RECEIVED
Tuesday, July 7, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2009NOTICE OF PUBLICATION
Thursday, March 12, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 12, 2009ASSIGNED TO LIE
Wednesday, March 11, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 6, 2009EXAMINER'S AMENDMENT ENTERED
Friday, March 6, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2009EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 17, 2009NON-FINAL ACTION WRITTEN
Tuesday, February 17, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 17, 2009NON-FINAL ACTION E-MAILED
Tuesday, February 17, 2009NON-FINAL ACTION WRITTEN
Monday, February 9, 2009ASSIGNED TO EXAMINER
Monday, December 22, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

eidetica disorders hormonal coagulation enzyme blood replacement therapies diseases preparations metabolic